Oligosaccharide and glycoprotein microarrays as tools in HIV glycobiology: Glycan-dependent gp120/protein interactions

Chemistry and Biology

Volumn 11, Issue 6, 2004, Pages 875-881

  Adams, Eddie W ^a   Ratner, Daniel M ^a   Bokesch, Heidi R ^b   McMahon, James B ^c   O'Keefe, Barry R ^c   Seeberger, Peter H ^a,d  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b SAIC FREDERICK INC   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; GLYCOPROTEIN GP 120; OLIGOSACCHARIDE; POLYSACCHARIDE;

ARTICLE; BINDING COMPETITION; CARBOHYDRATE ANALYSIS; CHEMISTRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; METHODOLOGY; MICROARRAY ANALYSIS; MOLECULAR GENETICS; PHYSIOLOGY; PROTEIN BINDING; PROTEIN MICROARRAY;

BINDING, COMPETITIVE; CARBOHYDRATE SEQUENCE; GLYCOPROTEINS; HIV; HIV ENVELOPE PROTEIN GP120; HUMANS; MICROARRAY ANALYSIS; MOLECULAR SEQUENCE DATA; OLIGOSACCHARIDES; POLYSACCHARIDES; PROTEIN ARRAY ANALYSIS; PROTEIN BINDING;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 3042646556     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2004.04.010     Document Type: Article

References (32)

1. Wyatt R., Sodroski J. The HIV-1 envelope glycoproteins. fusogens, antigens, and immunogens Science. 280:1998;1884-1888
2. Poignard P., Saphire E.O., Parren P.W., Burton D.R. gp120. Biologic aspects of structural features Annu. Rev. Immunol. 19:2001;253-274
3. Burton D.R. A vaccine for HIV type 1. the antibody perspective Proc. Natl. Acad. Sci. USA. 94:1997;10018-10023
4. Kwong P.D., Doyle M.L., Casper D.J., Cicala C., Leavitt S.A., Majeed S., Steenbeke T.D., Venturi M., Chaiken I., Fung M., et al. HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites. Nature. 420:2002;678-682
5. Wyatt R., Kwong P.D., Desjardins E., Sweet R.W., Robinson J., Hendrickson W.A., Sodroski J.G. The antigenic structure of the HIV gp120 envelope glycoprotein. Nature. 393:1998;705-711
6. Scanlan C.N., Pantophlet R., Wormald M.R., Ollmann Saphire E., Stanfield R., Wilson I.A., Katinger H., Dwek R.A., Rudd P.M., Burton D.R. The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of α1→2 mannose residues on the outer face of gp120. J. Virol. 76:2002;7306-7321
7. Calarese D.A., Scanlan C.N., Zwick M.B., Deechongkit S., Mimura Y., Kunert R., Zhu P., Wormald M.R., Stanfield R.L., Roux K.H., et al. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Science. 300:2003;2065-2071
8. Chan D.C., Kim P.S. HIV entry and its inhibition. Cell. 93:1998;681-684
9. Howard O.M., Korte T., Tarasova N.I., Grimm M., Turpin J.A., Rice W.G., Michejda C.J., Blumenthal R., Oppenheim J.J. Small molecule inhibitor of HIV-1 cell fusion blocks chemokine receptor-mediated function. J. Leukoc. Biol. 64:1998;6-13
10. Boyd M.R., Gustafson K.R., McMahon J.B., Shoemaker R.H., O'Keefe B.R., Mori T., Gulakowski R.J., Wu L., Rivera M.I., Laurencot C.M., et al. Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120. potential applications to microbicide development Antimicrob. Agents Chemother. 41:1997;1521-1530
11. Bolmstedt A.J., O'Keefe B.R., Shenoy S.R., McMahon J.B., Boyd M.R. Cyanovirin-N defines a new class of antiviral agent targeting N-linked, high-mannose glycans in an oligosaccharide-specific manner. Mol. Pharmacol. 59:2001;949-954
12. Tsai C.C., Emau P., Jiang Y., Tian B., Morton W.R., Gustafson K.R., Boyd M.R. Cyanovirin-N gel as a topical microbicide prevents rectal transmission of SHIV89.6P in macaques. AIDS Res. Hum. Retroviruses. 19:2003;535-541
13. Drickamer K., Taylor M.E. Glycan arrays for functional glycomics. Genome Biol. 3(reviews):2002;1034
14. Adams E.W., Ueberfeld J., Ratner D.M., O'Keefe B.R., Walt D.R., Seeberger P.H. Encoded fiber-optic microsphere arrays for probing protein-carbohydrate interactions. Angew. Chem. Int. Ed. Engl. 42:2003;5317-5320
15. Ratner D.M., Adams E.W., O'Keefe B., Mrksich M., Seeberger P.H. Probing protein-carbohydrate interactions with microarrays of synthetic oligosaccharides. Chembiochem. 5:2004;379-383
16. Geijtenbeek T.B., Torensma R., van Vliet S.J., van Duijnhoven G.C., Adema G.J., van Kooyk Y., Figdor C.G. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell. 100:2000;575-585
17. Bokesch H.R., O'Keefe B.R., McKee T.C., Pannell L.K., Patterson G.M., Gardella R.S., Sowder R.C. 2nd, Turpin J., Watson K., Buckheit R.W. Jr., et al. A potent novel anti-HIV protein from the cultured cyanobacterium Scytonema varium. Biochemistry. 42:2003;2578-2584
18. Johnson W.E., Sauvron J.M., Desrosiers R.C. Conserved, N-linked carbohydrates of human immunodeficiency virus type 1 gp41 are largely dispensable for viral replication. J. Virol. 75:2001;11426-11436
19. O'Keefe B.R., Shenoy S.R., Xie D., Zhang W., Muschik J.M., Currens M.J., Chaiken I., Boyd M.R. Analysis of the interaction between the HIV-inactivating protein cyanovirin-N and soluble forms of the envelope glycoproteins gp120 and gp41. Mol. Pharmacol. 58:2000;982-992
20. Esser M.T., Mori T., Mondor I., Sattentau Q.J., Dey B., Berger E.A., Boyd M.R., Lifson J.D. Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120. J. Virol. 73:1999;4360-4371
21. Shenoy S.R., Barrientos L.G., Ratner D.M., O'Keefe B.R., Seeberger P.H., Gronenborn A.M., Boyd M.R. Multisite and multivalent binding between cyanovirin-N and branched oligomannosides. calorimetric and NMR characterization Chem. Biol. 9:2002;1109-1118
22. Sanders R.W., Venturi M., Schiffner L., Kalyanaraman R., Katinger H., Lloyd K.O., Kwong P.D., Moore J.P. The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120. J. Virol. 76:2002;7293-7305
23. Ratner, D.M., Plante, O.J., and Seeberger, P.H. (2002). A linear synthesis of branched high-mannose oligosaccharides from the HIV-1 viral surface envelope glycoprotein gp120. Eur. J. Org. Chem., 826-833.
24. Geijtenbeek T.B., Kwon D.S., Torensma R., van Vliet S.J., van Duijnhoven G.C., Middel J., Cornelissen I.L., Nottet H.S., KewalRamani V.N., Littman D.R., Figdor C.G., van Kooyk Y. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell. 100:2000;587-597
25. Feinberg H., Mitchell D.A., Drickamer K., Weis W.I. Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR. Science. 294:2001;2163-2166
26. Kwon D.S., Gregorio G., Bitton N., Hendrickson W.A., Littman D.R. DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection. Immunity. 16:2002;135-144
27. Mitchell D.A., Fadden A.J., Drickamer K. A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands. J. Biol. Chem. 276:2001;28939-28945
28. Van Die I., Van Vliet S.J., Nyame A.K., Cummings R.D., Bank C.M., Appelmelk B., Geijtenbeek T.B., Van Kooyk Y. The dendritic cell-specific C-type lectin DC-SIGN is a receptor for Schistosoma mansoni egg antigens and recognizes the glycan antigen Lewis x. Glycobiology. 13:2003;471-478
29. Drickamer K. Ca(2+)-dependent sugar recognition by animal lectins. Biochem. Soc. Trans. 24:1996;146-150
30. Meanwell N.A., Kadow J.F. Inhibitors of the entry of HIV into host cells. Curr. Opin. Drug Discov. Dev. 6:2003;451-461
31. Pohlmann S., Doms R.W. Evaluation of current approaches to inhibit HIV entry. Curr. Drug Targets Infect. Disord. 2:2002;9-16
32. Wei X., Decker J.M., Wang S., Hui H., Kappes J.C., Wu X., Salazar-Gonzalez J.F., Salazar M.G., Kilby J.M., Saag M.S., et al. Antibody neutralization and escape by HIV-1. Nature. 422:2003;307-312